Mycobacterium hemophilum infection presenting as filamentary keratopathy in an immunocompromised adult

Cornea

Volumn 26, Issue 6, 2007, Pages 764-766

  Millar, Michael James ^a   Bulliard, Carl ^a,b   Balachandran, Chandra ^a   Maloof, Anthony J ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Filamentary keratopathy; Graft versus host disease; Immunosuppression; Lepromatous leprosy; Mycobacterium hemophilum

Indexed keywords

ACETYLCYSTEINE; CARBOXYMETHYLCELLULOSE; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; EYE DROPS; IMMUNOSUPPRESSIVE AGENT; LUBRICATING AGENT; MOXIFLOXACIN; PARAFFIN; VALACICLOVIR;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; CONJUNCTIVAL BIOPSY; DERMATOLOGY; DRY EYE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KERATOPATHY; LEPROMATOUS LEPROSY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM HAEMOPHILUM; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAINING;

CONJUNCTIVAL DISEASES; CORNEAL DISEASES; EYE INFECTIONS, BACTERIAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM INFECTIONS;

EID: 34447521900     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318059b571     Document Type: Article

References (16)

1. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215-233.
2. Kim S. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006;17:344-348.
3. White DA, Kiehn TE, Bondoc AY, et al. Pulmonary nodule due to Mycobacterium haemophilum in an immunocompetent host. Am J Respir Crit Care Med. 1999;160:1366-1368.
4. Smith S, Taylor GD, Fanning EA. Chronic cutaneous Mycobacterium haemophilum infection acquired from coral injury. Clin Infect Dis. 2003;37:100-101.
5. Kraus M, Benharroch D, Kaplan D. Mycobacterial cervical lymphadenitis: the histological features of non-tuberculous mycobacterial infection. Histopathology. 1999;35:534-538.
6. Olsen RJ, Cernoch PL, Land GA. Mycobacterial synovitis caused by slow-growing nonchromogenic species: eighteen cases and a review of the literature. Arch Pathol Lab Med. 2006;130:783-791.
7. Elsayed S, Read R. Mycobacterium haemophilum osteomyelitis: case report and review of the literature. Available at http://www.biomedcentral. com/1471-2334/6/70. Accessed December 10, 2006.
8. Sompolinsky D, Lagziel A, Naveh D, et al. Mycobacterium haemophilum sp. nov., a new pathogen of humans. Int J Syst Bacteriol. 1978;28:67-75.
9. Shah MK, Sebti A, Kiehn TE, et al. Mycobacterium haemophilum in immunocompromised patients. Clin Infect Dis. 2001;33:330-337.
10. Elliott DC. An interpretation of the ocular manifestations of leprosy. Ann N Y Acad Sci. 1951;54:84-100.
11. Saubolle MA, Klein TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev. 1996;9:435-447.
12. van Besien K. Standardizing chronic graft-versus-host disease. Future Oncol. 2006;2:459-462.
13. McBride ME, Rudolph AH, Tschen JA, et al. Diagnostic and therapeutic considerations for cutaneous Mycobacterium haemophilum infections. Arch Dermatol. 1991;127:276-277.
14. Dever I, Martin JW, Seaworth B, et al. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis. 1992;14:1195-1200.
15. Branger B, Gouby A, Oules R, et al. Mycobacterium haemophilum and Mycobacterium xenopi associated infection in a renal transplant patient. Clin Nephrol. 1985;23:4-9.
16. Bernard EM, Edwares FF, Kiehn TE, et al. Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother. 1993;37:2323-2326.